Data updated: Mar 10, 2026
GALLIUM CITRATE GA 67
GALLIUM CITRATE GA-67
Approved 1976-05-17
4
Indications
--
Phase 3 Trials
1
Priority Reviews
49
Years on Market
Details
- Status
- Discontinued
- First Approved
- 1976-05-17
- Routes
- INJECTION
- Dosage Forms
- INJECTABLE
GALLIUM CITRATE GA 67 Approval History
Loading approval history...
What GALLIUM CITRATE GA 67 Treats
4 FDA approvalsOriginally approved for its first indication in 1976 . Covers 4 distinct patient populations.
- Other (4)
Other
(4 approvals)- • Approved indication (May 1976) Priority
- • Approved indication (Dec 1977)
- • Approved indication (Feb 1979)
- • Approved indication (Nov 1979)
🔬
Pro Active Pipeline
Ongoing clinical trials by development phase
Loading...
⭐
Pro Key Completed Trials
Completed studies with published results, ranked by significance
Loading...
📊
Trial Timeline
Full development history with FDA approval milestones
Loading...
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
GALLIUM CITRATE GA 67 FDA Label Details
ProWant competitive intelligence?
See who's developing similar drugs and track their progress
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.